When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says

[ad_1]


The Serum Institute of India said, “Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials.”

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *